PMDA drug package insert
温清飲エキス散〔勝昌〕
PMDA OTC drug · （株）東洋薬行 · package insert Mar 18, 2022
Key facts
| Brand names | 温清飲エキス散〔勝昌〕 |
|---|---|
| Companies | 製造販売元／（株）東洋薬行 |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 散剤 |
| OTC effect category | 温清飲 |
| Package insert date | Mar 18, 2022 |
| PMDA document key | 480213_J0601008605 |
| PMDA company code | 480213 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: